Protective effects of melatonin on gamma-ray induced intestinal damage.
OBJECTIVE
To examine the protective effects of melatonin on intestinal damage induced by gamma-rays.


METHODS
Six-week-old Slc:ICR male mice were used. Mice were given whole-body irradiation at various exposure doses (7-21 Gy) with (137)Cs gamma-rays (0.98 Gy/min). The mice were orally administered 1 ml of either 1% carboxymethyl cellulose sodium salt (CMC) or melatonin (1, 5, 10 or 20 mg/ml) freshly prepared as a uniform suspension in CMC before or after irradiation. The concentrations of plasma melatonin were determined by the radioimmunoassay (RIA) method. The mice were killed at 3.5 days after the exposure. The jejunum was removed, fixed in formalin and then stained with hematoxylin and eosin. The numbers of crypts per transverse circumference were counted using a microscope for 10 histological sections of each mouse.


RESULTS
The intestinal damage caused by gamma-ray irradiation was prevented by melatonin correlating to dosage. The D(0) (slope of the dose-survival curve) value significantly (p < 0.05) increased from 1.55 +/- 0.19 (mean +/- SD) Gy to 1.98 +/- 0.16 Gy by orally administering 20 mg melatonin 30 min before irradiation. The radioprotective effect of melatonin continued for 6 h after the administration.


CONCLUSIONS
Melatonin is judged to be a potential protector against intestinal damage associated with radiotherapy. Further experimental and clinical studies on this subject are needed to allow its use for radiotherapy.
Monobe
Manami
M
Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Chiba, Japan. monobe@affrc.go.jp
Hino
Makiko
M
Sumi
Mariko
M
Uzawa
Akiko
A
Hirayama
Ryoichi
R
Ando
Koichi
K
Kojima
Shuji
S
D000818:Animals; D005720:Gamma Rays / Q000009:adverse effects*; D007583:Jejunum / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects*; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D051379:Mice; D008813:Mice, Inbred ICR; D011832:Radiation Injuries / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000008:administration & dosage; D016896:Treatment Outcome; D014916:Whole-Body Irradiation / Q000009:adverse effects*
D011837:Radiation-Protective Agents; D008550:Melatonin